Elite Pharmaceuticals Names Aqeel Fatmi, John LaRocca to Board

Bitget2026/11/03 12:32

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Elite Pharmaceuticals elected Aqeel A. Fatmi and John W. LaRocca to its board on October 28, 2026.
The appointments expanded the board from four to six directors.
Fatmi previously served as chief scientific officer of Patheon and Banner Life Sciences from 2013 to 2016.
LaRocca served as Y-mAbs Therapeutics' senior vice president, general counsel and corporate secretary from January 2024 to October 2025.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Elite Pharmaceuticals Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 202611030730NEWSFILECNPR____20261103_322245_1) on November 03, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Elite Pharmaceuticals Names Aqeel Fatmi, John LaRocca to Board

You may also like

Crypto prices